Table 3. Progression-free survival (PFS) in the intent-to- treat (all randomized patients) population P + BSC BSC (n = 231) (n = 232) Progressed, n (%) 193 208 (90%) (84%) Censored, n (%) 38 (16%) 24 (10%) PFS (days) Median 56 51 95% CI (55-59) (50-54) Mean (SD) 96.4 (5.3) 59.7 (3.75) Min, max 0, 357 0, 337 Abbreviations: BSC, best supportive care; CI, confidence interval; P, panitumumab; SD, standard deviation